Sleep Aid Device is known as the devices which can provide solutions to an individualís sleeping disorder. Seeping aids device ensure the treatment and diagnosis for the sleep disturbances and disorders. The symptoms of sleep disorders normally include daytime sleepiness, irregular breathing and behaviours of abnormal sleeping and increasing movements during sleep. Sleep disorders has an very adverse effect to the human health. It can cause neural problems that can lead to the accidents, lower the productivity of work done by an individual and can also cause stress and depression. Moreover, sleep disorder can lead to some major chronic diseases like as cardiovascular diseases, obesity and diabetes
AMA Research have segmented the market of Global Sleep Aid Device market by Type, Application and Region. On the basis of Type, sleep apnea devices are dominating the market in the year 2020
On the basis of geography, the market of Sleep Aid Device has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Advancement in technology related to sleeping AID device
Growing healthcare facilities, and Surge in the demand for sleeping pills attributed to stressful modern lifestyle
Technological advancements leading to better adoption and Untapped markets in developing economies
- Adverse effects of sleep aid medication
- Patent expiration
In addition to the aforementioned factor, Growing healthcare facilities,
is expected to propel the growth of the market over the forecast period.
The key Players profiled in the study are Koninklijke Philips N.V. (Netherlands), Merck & Co. (United States), Sanofi (France), DeVilbiss Healthcare LLC. (United States), Pfizer Inc. (United States), SleepMed Inc. (United States), Cadwell Laboratories Inc (United States), Compumedics Limited (Australia), Natus Medical Incorporated (United States) and GlaxoSmithKline plc (United Kingdom). A lot of United States players are profiled in the research study indicating a strong market dependence.